Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$9.3 - $18.27 $67,220 - $132,055
-7,228 Reduced 25.92%
20,659 $200,000
Q2 2022

Aug 12, 2022

SELL
$11.79 - $27.63 $15,126 - $35,449
-1,283 Reduced 4.4%
27,887 $404,000
Q1 2022

May 11, 2022

SELL
$20.67 - $40.33 $1.46 Million - $2.84 Million
-70,469 Reduced 70.72%
29,170 $762,000
Q4 2021

Feb 08, 2022

SELL
$36.68 - $54.02 $710,234 - $1.05 Million
-19,363 Reduced 16.27%
99,639 $3.95 Million
Q3 2021

Nov 02, 2021

BUY
$49.57 - $58.15 $415,743 - $487,704
8,387 Added 7.58%
119,002 $5.95 Million
Q2 2021

Aug 11, 2021

BUY
$47.17 - $58.64 $196,840 - $244,704
4,173 Added 3.92%
110,615 $6.14 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $54.07 $399,381 - $507,987
9,395 Added 9.68%
106,442 $4.98 Million
Q4 2020

Feb 12, 2021

SELL
$31.9 - $44.89 $37,961 - $53,419
-1,190 Reduced 1.21%
97,047 $4.22 Million
Q3 2020

Nov 04, 2020

BUY
$28.55 - $36.91 $941,778 - $1.22 Million
32,987 Added 50.55%
98,237 $3.6 Million
Q2 2020

Jul 28, 2020

BUY
$24.0 - $32.87 $1.28 Million - $1.76 Million
53,420 Added 451.56%
65,250 $1.9 Million
Q1 2020

Apr 21, 2020

BUY
$17.8 - $37.6 $210,574 - $444,808
11,830 New
11,830 $309,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $378M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.